Global use of Haemophilus influenzae type b conjugate vaccine

作者：Ojo Linda R; O'Loughlin Rosalyn E; Cohen Adam L^*; Loo Jennifer D; Edmond Karen M; Shetty Sharmila S; Bear Allyson P; Privor Dumm Lois; Griffiths Ulla K; Hajjeh Rana

来源：Vaccine, 2010, 28(43): 7117-7122.

DOI：10.1016/j.vaccine.2010.07.074

• Haemophilus influenzae type b
• Vaccine
• Developing countries

Haemophilus influenzae type b (Hib) conjugate vaccines have been underutilized globally. We report progress in global use of Hib vaccines included in national immunization schedules. The number of countries using Hib vaccine increased from 89/193 (46%) in 2004 to 158/193 (82%) by the end of 2009. The increase was greatest among low-income countries eligible for financial support from the GAVI Alliance [13/75 (17%) in 2004, 60/72 (83%) by the end of 2009], and can be attributed to various factors. Additional efforts are still needed to increase vaccine adoption in lower middle income countries [20/31 (65%) by the end of 2009]. Published by Elsevier Ltd.

• 出版日期2010-10-8